References
1. Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg 1985; 72: 659–661.
2. Verbeek PC, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112: 866–871.
3. Rumalla A, Petersen BT. Diagnosis and therapy of biliary tract malignancy. Semin Gastrointest Dis 2000; 11: 168–173.
4. Zeff RH, Pfeffer RB, Adams PX, Ruoff M. Reoperation for amputation neuroma of the cystic duct. Am J Surg 1976; 131: 369–370.
5. Prinz RA, Greenlee HB, Caporale FS. Amputation neuroma of the cystic duct: A treatable cause of postcholecystectomy pain. Am Surg 1979; 45: 543–544.
6. Larson DM, Storsteen KA. Traumatic neuroma of the bile ducts with intrahepatic extension causing obstructive jaundice. Hum Pathol 1984; 15: 287–289.
7. Sugahara K, Yamamoto M, Iizuka H, Yoshioka M, Miura K. Spontaneous neuroma of the bile duct: A case report. Am J Gastroenterol 1985; 80: 807–809.
8. Rush BF Jr, Stefaniwsky AB, Sasso A, Dumitrescu I, Wexler D. Neuroma of the common bile duct. J Surg Oncol 1988; 39: 17–21.
9. Shumate CR, Curley SA, Cleary KR, Ames FC. Traumatic neuroma of the bile duct causing cholangitis and atrophy of the right hepatic lobe. South Med J 1992; 85: 425–427.
10. Nagata Y, Tomioka T, Chiba K, Kanematsu T. Traumatic neuroma of the common hepatic duct after laparoscopic cholecystectomy. Am J Gastroenterol 1995; 90: 1887–1888.
11. Pickens A, Vickers SM, Brown KL, Reddy VV, Thompson JA. An unusual etiology of biliary hilar obstruction and the potential role of acidic fibroblast growth factor in the development of a biliary neuroma. Am Surg 1999; 65: 47–51.
12. Koike N, Todoroki T, Kawamoto T, et al. Amputation neuroma mimics common hepatic duct carcinoma. Hepatogastroenterology 2000; 47: 639–643.
13. Knapen P, Ponette E, Marchal G, et al. Three cases of non-tumoural tight stenosis of the bifurcation of the hilar bile ducts. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1994; 161: 561–563.
14. Nakayama A, Imamura H, Shimada R, et al. Proximal bile duct stricture disguised as malignant neoplasm. Surgery 1999; 125: 514–521.
15. van Leeuwen DJ, Reeders JW. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 1999; 10 (Suppl 4): 89–93.
16. Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: Analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94: 1941–1946.
17. Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: Clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000; 26: 474–479.
18. Torok N, Gores GJ. Cholangiocarcinoma. Semin Gastrointest Dis 2001; 12: 125–132.
19. Bain VG, Abraham N, Jhangri GS, et al. Prospective study of biliary strictures to determine the predictors of malignancy. Can J Gastroenterol 2000; 14: 397–402.
20. Mendler MH, Bouillet P, Sautereau D, et al. Value of MR cholangiography in the diagnosis of obstructive diseases of the biliary tree: A study of 58 cases. Am J Gastroenterol 1998; 93: 2482–2490.
21. Blumgart LH, Kelley CJ, Benjamin IS. Benign bile duct stricture following cholecystectomy: Critical factors in management. Br J Surg 1984; 71: 836–843.
22. Blumgart LH, Kelley CJ. Hepaticojejunostomy in benign and malignant high bile duct stricture: Approaches to the left hepatic ducts. Br J Surg 1984; 71: 257–261.
23. Povoski SP, Karpeh M Jr, Conlon KC, et al. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg 1999; 3: 496–505.